Stock GMAB GENMAB A/S
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Genmab A/S

Equities

GMAB

DK0010272202

Delayed Nasdaq Copenhagen
Other stock markets
 10:59:36 2024-06-04 am EDT 		5-day change 1st Jan Change
1,938 DKK -0.82% Intraday chart for Genmab A/S +0.16% -10.09%
Jun. 04 Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating MT
Jun. 03 Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GENMAB A/S
Bio Therapeutic Drugs
-0.82%+0.16%-10.09%-28.82%+70.70% 18.16B
Neutral
Neutral
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. Charts Genmab A/S
  5. Comparison Chart